How can organisations fully realise the potential of strategic partnerships and maximise impact for patients?
Biopharma is facing increasing pressure to consistently deliver new, innovative products to patients, gain a competitive advantage, and meet greater stakeholder expectations.
We're exploring how organisations need to change the way they operate, at both an enterprise as well as partnership level, to fully realise the potential of strategic partnerships and maximise impact for patients.
Find out moreOur Insights
The Power of Partnerships in Pharma
How can strategic partnerships realise their potential within pharma and life sciences?
Read more
Unlocking the value of Digital and AI partnerships for Biopharma: in conversation with PathAI
Explore how digital and AI strategic partnerships for biopharma companies are shaping the future of precision medicine.
Read more
How powerful partnerships can unlock digital health innovation
Strategic partnerships offer an attractive route to unlock innovation within digital health however current failure rates sit at 60%. How can you build powerful partnerships?
Read more
Building stronger strategic partnerships in R&D
The establishment of strategic partnerships is increasingly recognised as a means to enhance innovation and drive future growth within research and development (R&D).
Read more
Patient-Centric Biopharma Transformation
Beyond the science, the commercial landscape around healthcare has drastically changed and patients expect more. Traditional communication channels for HCPs are obsolete, and a new, digitally-integrated approach is needed to effectively engage them. Our Baringa experts will help you navigate this new landscape to help ensure no patient is left behind.
Read moreRelated Client Stories
Laying the foundational human factors to enable data, digital and AI collaboration
A global top 10 biopharmaceutical organisation recognised the need to lay foundational human factors to unlock the potential of data, digital and AI innovation.
Read more
Designing and implementing an end-to-end partnering framework for a global biopharma
A global top 10 biopharmaceutical organisation required our support to design and implement an enterprise-wide and end-to-end operating framework for how they manage R&D collaborations.
Read more
Overcoming partnering challenges in a leading oncology strategic alliance
Identifying the root causes of the challenges that were holding back the pace and effectiveness of the strategic oncology alliance.
Read more
Discussion with LifeArc: the challenges around operationalising patient centricity
Kate Moss talks discusses patients and patient centricity, the difficulties around operationalising and the challenges of making a difference for patients with Dr Melanie Lee, CEO of our client LifeArc.
Read moreOur Impact
Laying the foundational human factors to enable data, digital and AI collaboration
A global top 10 biopharmaceutical organisation recognised the need to lay foundational human factors to unlock the potential of data, digital and AI innovation.
Read more
Overcoming partnering challenges in a leading oncology strategic alliance
Identifying the root causes of the challenges that were holding back the pace and effectiveness of the strategic oncology alliance.
Read more
Designing and implementing an end-to-end partnering framework for a global biopharma
A global top 10 biopharmaceutical organisation required our support to design and implement an enterprise-wide and end-to-end operating framework for how they manage R&D collaborations.
Read more
Supporting medical research charity LifeArc with its transformation
We speak with Dr Melanie Lee, CEO of medical research charity LifeArc, about how we supported them on their transformation and the legacy we left with our client.
Read moreOur Offerings
Research and development
Companies face increasing costs to develop and commercialise more effective and personalized treatments, all while regulators, public healthcare systems and patients demand greater affordability.
Bringing deep industry expertise and proven strategy through implementation experience, our biopharma and biotech consultants know how to strike this delicate balance, helping clients simplify and streamline operations to lift R&D efficiency, increase agility and accelerate innovation.
Supply chain
Novel life sciences models and modes of care, along with changing patient expectations and policy shifts, are placing greater demands on the supply chain than ever.
Supported by our expert consulting services, clients can take control of this complexity to improve collaboration with all stakeholders and act with greater agility.
Our pharmaceutical supply chain solutions enable organisations to transform end-to-end operations to be more resilient, sustainable and patient-centric.
Commercial
More connected, data-driven and consumer-focused than ever, healthcare has changed – and so too have the markers of success.
We transform commercial functions to thrive in the new normal, harnessing data, science, technology and people to shape seamless customer experiences.
We have the deep expertise to forge strong links across functional silos and the end-to-end development lifecycle – empowering pharma and biotech firms to build truly patient-centric, profitable businesses.
Patients
Patients expect more meaningful, convenient and high-quality experiences across the healthcare continuum, while advances in data, science and technology mark a new chapter for disease intervention and treatment.
We help clients navigate an increasingly complex healthcare landscape and build the capabilities needed to get closer to patients, their healthcare providers and wider support network – inspiring organisations to bring their visions for holistic, patient-centric care to life.
Our Experts
Are digital and AI delivering what your business needs?
Digital and AI can solve your toughest challenges and elevate your business performance. But success isn’t always straightforward. Where can you unlock opportunity? And what does it take to set the foundation for lasting success?